辰欣药业(603367.SH)股东韩延振拟减持不超3%股份

Core Viewpoint - Chenxin Pharmaceutical (603367.SH) announced a plan for share reduction by its shareholder Han Yanzhen, which will take place within three months after a 15 trading day period following the announcement [1] Summary by Category Share Reduction Plan - Han Yanzhen intends to reduce holdings through centralized bidding, with a maximum of 4.5275 million shares, accounting for no more than 1% of the company's total share capital [1] - Additionally, Han Yanzhen plans to reduce holdings via block trading, with a maximum of 9.0551 million shares, representing no more than 2% of the company's total share capital [1] - The total reduction will not exceed 13.5826 million shares, which is up to 3% of the company's total share capital [1]